NASDAQ

PROVO, UT / ACCESSWIRE / May 12, 2023 / Sunworks, Inc. (Nasdaq:SUNW, "Sunworks" or the "Company"), a leading provider of solar power and battery storage solutions for residential, agriculture, commercial, industrial, and public works markets, today announced that it intends to postpone the issuance of its first quarter 2023 results…

Ainos continues its strategic transition away from marketing COVID test kits and further advances commercialization of its VELDONA® and VOC POCT technologies Strategic pivot is underpinned by Ainos' diversified product pipeline SAN DIEGO, CA / ACCESSWIRE / May 12, 2023 / Ainos, Inc.Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos", or the "Company"),…

TAMPA, FL / ACCESSWIRE / May 12, 2023 / Generation Income Properties, Inc. (NASDAQ:GIPR) ("GIPR" or the "Company") today announced its financial and operating results for the three-month period ended March 31, 2023. Highlights (For the 3 months ended March 31, 2023) Generated net loss attributable to GIPR of ($1.3…

We use cookies and data to Deliver and maintain Google servicesTrack outages and protect against spam, fraud, and abuseMeasure audience engagement and site statistics to understand how our services are used and enhance the quality of those servicesIf you choose to “Accept all,” we will also use cookies and data…

Author of the article: Published May 12, 2023  •  1 minute read TORONTO & NEW YORK — The Real Brokerage Inc. (TSX: REAX) (NASDAQ: REAX), the fastest-growing publicly traded real estate brokerage, today announced that Chairman and Chief Executive Officer Tamir Poleg will be presenting at the 18th Annual Needham…

Executive Chairman Hermann Luebbert to Assume CEO Responsibilities, Reaffirms the Company's Strategic Plan and 2023 Commercial Goals WOBURN, MA / ACCESSWIRE / May 12, 2023 / Biofrontera Inc. (Nasdaq:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic products, announces the resignation of Erica Monaco as Chief Executive…

Median progression free survival (PFS) was 48.6 months in treatment-naïve patients with HR+/HER2- advanced breast cancer who were treated with gedatolisib in combination with palbociclib and letrozole Median duration of response (DOR) was 46.9 months MINNEAPOLIS, MN / ACCESSWIRE / May 12, 2023 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology…

Troubles in the American banking industry continue as the shares of PacWest Bancorp (NASDAQ: PACW) decrease 23 percent on Thursday after the regional bank disclosed a massive deposit outflow. The California-based lender disclosed in a filing on Thursday with the Securities and Exchange Commission (SEC) that it had lost 9.5…

Fintel reports that on May 11, 2023, RBC Capital maintained coverage of Verisk Analytics (NASDAQ:VRSK) with a Outperform recommendation. Analyst Price Forecast Suggests 4.09% Upside As of May 11, 2023, the average one-year price target for Verisk Analytics is 223.23. The forecasts range from a low of 179.78 to a…

NEW YORK / PARIS / TOKYO, May 11, 2023 - (ACN Newswire) - The future of travel is here. After months of anticipation, Travelzoo META, a members-only service offering groundbreaking Metaverse travel experiences, is now accepting its first one million Founding Members. Launched by Travelzoo(R) (NASDAQ: TZOO), a global Internet…